Trial
NCT04346225
Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer
Phase IISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Ivan de Kouchkovsky, MD
Collaborators
National Cancer Institute (NCI); National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Condition
Prostate Cancer
Intervention
Hyperpolarized C13
Why stopped
Due to funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-23